(1-Methyl-1H-pyrazol-5-yl)methanamine hydrochloride, 95+%, 1g

3-Chloro-5-nitrobenzoic acid, 95.0%, 5g

cyclopropyl 4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone, 97.0%, 1g

E-64d [for Biochemical Research]>95.0%(HPLC)5mg

(2-(4-Fluorophenyl)cyclopropyl)methanamine hydrochloride, 98%, 1g

N-[2-(Methacryloyloxy)ethyl]-N,N-dimethylbutan-1-aminium Bis(trifluoromethanesulfonyl)imide>98.0%(HPLC)(N)5g

2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine>98.0%(HPLC)(T)25g

2,4-Dimethoxybenzaldehyde, 98.0%, 25g

2-(chloromethyl)-6,7-dimethyl-1H-benzimidazole, 95.0%, 1g

3-(2-METHYLPHENOXY)BENZYLAMINE HCL, 95.0%, 250mg

Plaques de support ROTILABO® forme haute, 130 mm, 210 mm, 1 pièce

2-Bromo-4-morpholin-4-yl-benzaldehyde, 100mg

5-Bromo-2-(isopropoxy)pyridine-4-boronic acid, 98%, 500mg